Results 11 to 20 of about 235,874 (246)
A Development of a Human Cranial Bone Surrogate for Impact Studies
Frontiers in Bioengineering and Biotechnology, 2013 In order to replicate the fracture behavior of the intact human skull under impact it becomes necessary to develop a material having the mechanical properties of cranial bone.
Jack C Roberts +7 more
doaj +1 more source
High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice [PDF]
, 2011 Background: We have empirically noted that many physicians routinely request anti-phospholipid antibodies (aPL) without a correct clinical indication. The aim of this study was to evaluate retrospectively whether aPL testing at our Thrombosis Centre was ...
Barcellona D +3 more
core +1 more source
IEEE Access, 2022 A low-profile circularly-polarized sequential rotation fed $4\times 4$ array antenna working in the Ka-band from 27.5 GHz to 31 GHz is presented. The particularity of the antenna lies in its single-layer sequential rotation feed network implemented in ...
Miguel Ferrando-Rocher +3 more
doaj +1 more source
Locking Local Oscillator Phase to the Atomic Phase via Weak Measurement [PDF]
, 2012 We propose a new method to reduce the frequency noise of a Local Oscillator (LO) to the level of white phase noise by maintaining (not destroying by projective measurement) the coherence of the ensemble pseudo-spin of atoms over many measurement cycles ...
Dehmelt H +6 more
core +1 more source
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
Leukemia and Lymphoma, 2019 The application of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has revolutionized the treatment of acute promyelocytic leukemia (APL). More than 80–90% of patients are expected to be cured with a combination of ATRA, ATO and/or chemotherapy.
M. Stahl, M. Tallman
semanticscholar +1 more source
Frontiers in Immunology, 2019 Objective: Antiphospholipid antibodies (aPL) are risk factors for thrombosis and adverse pregnancy outcomes (APO). The management of the so called “aPL carriers” (subjects with aPL positivity without the clinical criteria manifestations of APS) is still ...
M. Lazzaroni +15 more
semanticscholar +1 more source
Blood, 2018 Pediatric acute promyelocytic leukemia (APL) can be cured with all-trans retinoic acid (ATRA) and anthracycline. However, most published trials have employed high cumulative doses of anthracyclines.
A. Testi +17 more
semanticscholar +1 more source
Applied Sciences, 2020 Direct sound that is captured by the upper layer of a three-dimensional (3D) microphone array is typically regarded as vertical interchannel crosstalk (VIC), since it tends to produce an undesired effect of the sound source image being elevated from the ...
Rory Wallis, Hyunkook Lee
doaj +1 more source
Anti-phospholipid-antibodies in patients with relapsing polychondritis [PDF]
, 1998 Relapsing polychondritis (RP) is an extremly rare multisystemic disease thought to be of autoimmune origin. In order to assess if RP is associated with anti-phospholipid antibodies (aPL), clinical data and sera of 21 patients with RP were collected in a ...
B Lang +11 more
core +1 more source
American journal of hematology/oncology, 2018 Intravenous arsenic trioxide (ATO) has been adopted as the first‐line treatment for acute promyelocytic leukemia (APL). Another arsenic compound named the Realgar‐Indigo naturalis formula (RIF), an oral traditional Chinese medicine containing As4S4, has ...
Ming-Hua Yang +17 more
semanticscholar +1 more source